UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

(Mark one)

 

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2016

 

OR

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from             to       

 

Commission File Number:  001-12648

 

UFP Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

 

100 Hale Street, Newburyport, Massachusetts 01950, USA

(Address of principal executive offices)  (Zip Code)

 

(978) 352-2200

(Registrant's telephone number, including area code)

 

(Former name, former address, and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒;  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒;  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ☐ ;  No  ☒

 

7,185,897 shares of registrant’s Common Stock, $0.01 par value, were outstanding as of May 2, 2016.

 

 

 

 

UFP Technologies, Inc.

 

Index

 

 

 

PART I:FINANCIAL INFORMATION

ITEM 1:FINANCIAL STATEMENTS

 

UFP Technologies, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except share data)

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

UFP Technologies, Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

UFP Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

Notes to Interim Condensed Consolidated Financial Statements

 

(1)      Basis of Presentation

 

The interim condensed consolidated financial statements of UFP Technologies, Inc. (the “Company”) presented herein, have been prepared pursuant to the rules of the Securities and Exchange Commission for quarterly reports on Form 10-Q and do not include all the information and note disclosures required by accounting principles generally accepted in the United States of America.  These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2015, included in the Company's 2015 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission.

 

The condensed consolidated balance sheet as of March 31, 2016, the condensed consolidated statements of income for the three- month periods ended March 31, 2016 and 2015, and the condensed consolidated statements of cash flows for the three- month periods ended March 31, 2016 and 2015 are unaudited but, in the opinion of management, include all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation of results for these interim periods.

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

The results of operations for the three- month period ended March 31, 2016 are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, 2016.

 

Recent Accounting Pronouncements

 

In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, Improvements to Employee Share Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards and classification on the statement of cash flows. The provisions of this ASU are effective for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. This amendment is applicable to us beginning in the first quarter of 2017. The Company is evaluating the impact of adopting this ASU on its consolidated financial position and results of operations.

 

 

(2)      Supplemental Cash Flow Information

 

Cash paid (received) for interest and income taxes is as follows (in thousands):

 

 

 

(3)      Fair Value Accounting

 

The Company has financial instruments, such as accounts receivable, accounts payable, and accrued expenses, which are stated at carrying amounts that approximate fair value because of the short maturity of those instruments.  The carrying amount of the Company’s long-term debt approximates fair value as the interest rate on the debt approximates the estimated borrowing rate currently available to the Company.

 

(4)      Share-Based Compensation

 

Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).

The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended December 31, 2015.  The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):

 

 

The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately $57,000 and $58,000, respectively, for the three-month periods ended March 31, 2016 and 2015.

 

The following is a summary of stock option activity under all plans for the three- month period ended March 31, 2016:

 

 

The Company did not grant any stock options during the first quarter of 2016.

 

During the three-month period ended March 31, 2015, the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately $600,000, and the total amount of consideration received by the Company from the exercised options was approximately $130,000. There were no options exercised during the three- month period ended March 31, 2016. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the three-months ended March 31, 2016 and 2015, there were no shares surrendered for this purpose.

 

During each of the three-month periods ended March 31, 2016 and 2015, the Company recognized compensation expense related to stock options granted to directors and employees of approximately $36,000 and $44,000, respectively.

 

On February 22, 2016, the Company’s Compensation Committee approved the award of $400,000,  payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the 2003 Incentive Plan.  The shares will be issued on December 22, 2016.  The Company recorded compensation expense associated with the award of $100,000 during the three-month period ended March 31, 2016. The Company recorded compensation expense associated with a similar award of $100,000, during the three-month period ended March 31, 2015. 

 

The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the three-month period ended March 31, 2016:

 

 

During the three-month periods ended March 31, 2016 and 2015, the Company recorded compensation expense related to RSUs of approximately $65,000 and $66,000, respectively.

 

At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax, and the remaining amount is converted into the equivalent number of common shares.  During the three-month periods ended March 31, 2016 and 2015, 3,889 and 3,405 shares were surrendered at an average market price of $22.82 and $23.15, respectively.

 

As of March 31, 2016, the Company had approximately $1.2 million of unrecognized compensation expense, which is expected to be recognized over a period of 4 years.

 

(5)      Inventories

 

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value, and consist of the following at the stated dates (in thousands):

 

 

 

 

(6)      Preferred Stock

 

On March 18, 2009, the Company declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock, par value $0.01 per share, to the stockholders of record on March 20, 2009.  Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.01 per share (the “Preferred Share”) of the Company, at a price of $25 per one one-thousandth of a Preferred Share subject to adjustment and the terms of the Rights Agreement.  The Rights expire on March 19, 2019.

 

(7)      Income Per Share

 

Basic income per share is based on the weighted average number of shares of common stock outstanding.  Diluted income per share is based upon the weighted average number of common shares outstanding and dilutive common stock equivalent shares outstanding during each period.

 

The weighted average number of shares used to compute basic and diluted net income per share consisted of the following (in thousands):

 

 

The computation of diluted earnings per share excludes the effect of the potential exercise of stock awards, including stock options, when the average market price of the common stock is lower than the exercise price of the related options during the period. These outstanding stock awards are not included in the computation of diluted income per share because the effect would be antidilutive.  For the three-month periods ended March 31, 2016 and 2015, the number of stock awards excluded from the computation of diluted earnings per share for this reason was 54,969 and 53,651, respectively.

 

(8)      Segment Reporting

 

The Company consists of a single operating and reportable segment.

 

Revenues from customers outside of the United States are not material.  No customer comprised more than 10% of the Company’s consolidated revenues for the three-month period ended March 31, 2016.  All of the Company’s assets are located in the United States.

 

The Company’s products are primarily sold to customers within the Medical, Automotive, Consumer, Electronics, Industrial and Aerospace and Defense markets.  Net sales by market for the three-month periods ended March 31, 2016 and 2015 are as follows (in thousands):

 

 

 

 

Note – certain amounts for the three-months ended March 31, 2015 were reclassified between markets to conform to the current period presentation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9)      Other Intangible Assets

 

The carrying values of the Company’s definite lived intangible assets as of March 31, 2016 and December 31, 2015, are as follows (in thousands):

 

 

Amortization expense related to intangible assets was approximately $80,000 and $79,000 for the three- month periods ended March 31, 2016 and 2015, respectively. The estimated remaining amortization expense as of March 31, 2016 is as follows (in thousands):

 

 

 

(10)     Income Taxes

 

The income tax expense included in the accompanying unaudited condensed consolidated statements of income principally relates to the Company’s proportionate share of the pre-tax income of its wholly-owned subsidiaries.  The determination of income tax expense for interim reporting purposes is based upon the estimated effective tax rate for the year, adjusted for the impact of any discrete items which are accounted for in the period in which they occur.

 

The Company recorded tax expense of approximately 37.3% of income before income tax expense for the three-month period ended March 31, 2016 and approximately 35.0% of income before income tax expense for the three- month period ended March 31, 2015. The increase in the effective tax rate for the current period is due to a tax assessment of approximately $40,000 from one jurisdiction.

 

(11)     Plant Consolidations

 

Restructuring Costs

 

On March 18, 2015, the Company committed to move forward with a plan to cease operations at its Raritan, New Jersey, plant and consolidate operations into its Newburyport, Massachusetts, facility and other UFP facilities. The Company’s decision was in response to a continued decline in business at the Raritan facility and the recent purchase of the 137,000-square-foot facility in Newburyport. The activities related to this consolidation were substantially complete at December 31, 2015.

 

The Company also relocated all operations in its Haverhill, Massachusetts, and Byfield, Massachusetts facilities and plans to relocate certain operations in its Georgetown, Massachusetts facility to Newburyport.  The Haverhill and Byfield relocations were complete at December 31, 2015 and the Georgetown relocation is expected to be complete by June 30, 2016.

 

The Company expects to incur approximately $2.1 million in one-time expenses in connection with the Massachusetts consolidations. Included in this amount are approximately $180,000 relating to employee severance payments and relocation costs, approximately $1.5 million in moving expenses and expenses associated with vacating the Raritan, Haverhill and Byfield properties, and approximately $360,000 in lease termination costs. Total cash charges are estimated at $2.0 million. The Company expects annual cost savings of approximately $1.0 million as a result of these consolidations. Through March 31, 2016, the Company had incurred approximately $1.8 million of the costs for this restructuring plan.

 

On July 16, 2014, the Company committed to move forward with a plan to cease operations at its Costa Mesa, California, plant and consolidate operations into its Rancho Dominguez, California, facility and other UFP facilities. The Company’s decision was in response to the December 31, 2014, expiration of the lease on the Costa Mesa facility as well as the close proximity of the two properties. The California consolidation is complete.

 

The company recorded the following restructuring costs associated with the above noted consolidations for the three-month periods ended March 31, 2016 and 2015 (in thousands):

 

 

 

 

 

 

 

 

Costs for the three months ended March 31, 2016 were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” from Cost of Sales.  Costs for the three months ended March 31, 2015 were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” as follows: $60,000 from Cost of Sales and $18,000 from General and Administrative expenses. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12) Related Party Transactions

 

Daniel Croteau, who has been a member of the Company’s board of directors since December 16, 2015, is the Chief Executive Officer of Vention Medical, Inc., a customer of the Company.  Sales to Vention for the first quarter of 2016 were approximately $106,000.  All accounts receivable from Vention were paid in full at March 31, 2016.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ITEM 2:MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-looking Statements

 

Some of the statements contained in this Report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). These statements are subject to known and unknown risks, uncertainties, and other factors, which may cause our or our industry’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about the Company’s prospects, anticipated trends in the different markets in which the Company competes, including the medical, automotive, consumer, electronics, industrial and aerospace and defense markets, anticipated new customer contracts, statements regarding anticipated advantages relating to the Company’s decisions to consolidate its Midwest, California and Northeast facilities and the expected cost savings and efficiencies associated therewith, anticipated advantages of maintaining fewer, larger plants, anticipated advantages the Company expects to realize from its investments and capital expenditures, including the development of and investments in its molded fiber product lines, anticipated advantages the Company expects to realize as a result of its new enterprise resource planning software system and the expected timing associated therewith, expectations regarding the manufacturing capacity and efficiencies of the Company and the expected timing associated therewith, statements about the Company’s acquisition opportunities and strategies, its participation and growth in multiple markets, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues, and any indication that the Company may be able to sustain or increase its sales and earnings or sales and earnings growth rates. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation risks and uncertainties associated with plant closures and expected efficiencies from consolidating manufacturing, the risk that we may not be able to finalize anticipated new customer contracts, risks associated with the implementation of new production equipment in a timely, cost-efficient manner, risks that any benefits from such new equipment may be delayed or not fully realized, or that the Company may be unable to fully utilize its expected production capacity, and risks and uncertainties associated with the identification of suitable acquisition candidates and the successful, efficient execution of acquisition transactions and integration of any such acquisition candidates.  Accordingly, actual results may differ materially.

 

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential,” and similar expressions intended to identify forward-looking statements. Our actual results could be different from the results described in or anticipated by our forward-looking statements due to the inherent uncertainty of estimates, forecasts, and projections, and may be materially better or worse than anticipated. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements represent our estimates and assumptions only as of the date of this Report. We expressly disclaim any duty to provide updates to forward-looking statements, and the estimates and assumptions associated with them, after the date of this Report, in order to reflect changes in circumstances or expectations, or the occurrence of unanticipated events, except to the extent required by applicable securities laws. All of the forward-looking statements are qualified in their entirety by reference to the factors discussed above and under “Risk Factors” set forth in Part I Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as well as the risks and uncertainties discussed elsewhere in this Report. We qualify all of our forward-looking statements by these cautionary statements. We caution you that these risks are not exhaustive. We operate in a continually changing business environment and new risks emerge from time to time.

 

Unless the context requires otherwise, the terms “we”, “us”, “our”, or “the Company” refer to UFP Technologies, Inc. and its consolidated subsidiaries.

 

Overview

 

UFP Technologies is an innovative designer and custom converter of foams, plastics, composites and natural fiber products, principally serving the medical, automotive, consumer, electronics, industrial and aerospace and defense markets. The Company consists of a single operating and reportable segment.

 

The Company’s first quarter results were impacted by expenses related to plant consolidations in both the Northeast and Midwest.  The additional expenses were largely in the form of higher material consumed and labor incurred in the manufacturing process as new staff was trained and transferred jobs were re-qualified by customers.  The Company expects these incremental costs to subside over the next two quarters as training continues and more equipment and parts get qualified.  The Company further expects the completion of the transfer of certain equipment from its Georgetown, Massachusetts location into its newly acquired Newburyport, Massachusetts location by the end of the second quarter.

 

The Company continues to see robust growth in sales to customers in the medical market.  This growth is offsetting softness in sales to customers in the automotive and aerospace and defense markets.

 

The Company’s current strategy includes organic growth and growth through strategic acquisitions.

 

Results of Operations

 

Sales

 

Sales for the three-month period ended March 31, 2016 increased approximately 1.5% to $34.5 million from sales of $34.0 million for the same period in 2015. The increase in sales for the three-month period ended March 31, 2016 was primarily due to a 13.3% increase in sales to customers in the medical market partially offset by a 17.6% decline in sales to customers in the automotive market.  The increase in medical sales was largely due to recently awarded contracts as well as increased demand for customer products.   The decline in automotive sales was largely due to longer shutdowns at certain customers in January as well as disrupted manufacturing at one of the Company’s key customers due to a relocation of production to a new facility.

 

Gross Profit

 

Gross profit as a percentage of sales (“gross margin”) decreased to 22.4% for the three-month period ended March 31, 2016, from 25.4% for the same period in 2015.  As a percentage of sales, material and labor costs collectively increased 3.7%, while overhead decreased 0.6%.  The increase in collective material and labor costs as a percentage of sales is primarily due to incremental material consumed and labor incurred resulting from recent plant consolidations.  The decrease in overhead as a percentage of sales is primarily due to lower occupancy costs resulting from recent plant consolidations.  As noted above, the Company anticipates that the manufacturing inefficiencies will gradually subside.

 

Selling, General and Administrative Expenses

 

Selling, general, and administrative expenses (“SG&A”) decreased approximately 2.0% to $5.9 million for the three-month period ended March 31, 2016, from $6.0 million for the same period in 2015. As a percentage of sales, SG&A decreased to 17.1% for the three-month period ended March 31, 2016, from 17.7% for the same three-month period in 2015. The decrease in SG&A and SG&A as a percentage of sales for the three-month period ended March 31, 2016, is primarily due to lower salaries, benefits and commissions expense resulting largely from recent plant consolidations.   

 

Restructuring Costs

 

For the three month period ended March 31, 2016, the Company incurred restructuring costs of approximately $123,000, compared to approximately $78,000 for the same period in 2015.

 

Additional information regarding restructuring costs can be found in Note 11 of the Notes to Interim Condensed Consolidated Financial Statements.

 

Interest Income and Expense

 

The Company had net interest income of approximately $11,000 and net interest expense of approximately $24,000 for the three-month periods ended March 31, 2016 and 2015, respectively. The decrease in net interest expense is primarily due to an increase in interest earned on money market accounts and certificates of deposit and decreasing interest costs on our term loans.

 

Income Taxes

 

The Company’s effective tax rate was approximately 37.3% and 35.0%, for the three-month periods ended March 31, 2016 and 2015, respectively.  The increase in the effective tax rate for the current period is due to a tax assessment of approximately $40,000 from one jurisdiction. The Company has deferred tax assets on its books associated with net operating losses generated in previous years. The Company has considered both positive and negative available evidence in its determination that the deferred tax assets are more likely than not to be realized, and has not recorded a tax valuation allowance at March 31, 2016. The Company will continue to assess whether the deferred tax assets will be realizable and, when appropriate, will record a valuation allowance against these assets. The amount of the net deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carry-forward period are reduced.

 

Liquidity and Capital Resources

 

The Company generally funds its operating expenses, capital requirements, and growth plan through internally generated cash and bank credit facilities.

 

Cash Flows

 

Net cash used in operations for the three-month period ended March 31, 2016 was approximately $2.4 million and was primarily a result of net income generated of $1.1 million, depreciation and amortization of approximately $1.4 million, share-based compensation of $0.2 million, a decrease in inventories of approximately $1.0 million and a decrease in refundable income taxes of approximately $0.3 million. These cash inflows and adjustments to income were offset by an increase in accounts receivable of approximately $2.9 million due in part to strong March sales, an increase in prepaid expenses of approximately $1.5 million due to upfront insurance premium payments and a decrease in accrued expenses of approximately $2.0 million primarily due to the payment of year-end commissions, profit sharing and employee bonuses.

 

Net cash used in investing activities during the three-month period ended March 31, 2016 was approximately $1.6 million and was primarily the result of additions of manufacturing machinery and equipment and the renovations of the new manufacturing and headquarters building in Massachusetts.

 

Net cash used in financing activities was approximately $0.3 million during the three-month period ended March 31, 2016, representing cash used to service term debt of approximately $0.2 million and restricted stock units vested of approximately $0.1 million.

 

Outstanding and Available Debt

 

The Company maintains an unsecured $40 million revolving credit facility with Bank of America, N.A. The credit facility calls for interest of LIBOR plus a margin that ranges from 1.0% to 1.5% or, at the discretion of the Company, the bank’s prime rate less a margin that ranges from 0.25% to zero. In both cases the applicable margin is dependent upon Company performance. Under the credit facility, the Company is subject to a minimum fixed-charge coverage financial covenant as well as a maximum total funded debt to EBITDA financial covenant. The Company’s $40 million credit facility matures on November 30, 2018.

 

As of March 31, 2016, the Company had no borrowings outstanding under the credit facility and the Company was in compliance with all covenants under the credit facility.

 

In 2012, the Company financed the purchase of two molded fiber machines through five-year term loans that mature in September 2017.  The annual interest rate is fixed at 1.83% and the loans are secured by the related molded fiber machines.  As of March 31, 2016, the outstanding balance of the term loan facility was approximately $1.6 million.

 

Future Liquidity

 

The Company requires cash to pay its operating expenses, purchase capital equipment, and to service its contractual obligations.  The Company’s principal sources of funds are its operations and its revolving credit facility.  The Company

used cash of approximately $2.4 million in operations during the three-month period ended March 31, 2016, and cannot guarantee that its operations will generate cash in future periods.  The Company’s longer-term liquidity is contingent upon future operating performance.

 

Throughout fiscal 2016, the Company plans to continue to add capacity to enhance operating efficiencies in its manufacturing plants.  The Company may also further expand its Newburyport, Massachusetts manufacturing plant. The Company may consider additional acquisitions of companies, technologies, or products that are complementary to its business.  The Company believes that its existing resources, including its revolving credit facility, together with cash expected to be generated from operations and funds expected to be available to it through any necessary equipment financings and additional bank borrowings, will be sufficient to fund its cash flow requirements, including capital asset acquisitions, through the next twelve months.

 

Stock Repurchase Program

 

On June 16, 2015, the Company announced that its Board of Directors authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock. Under the program, the Company is authorized to repurchase shares through Rule 10b5-1 plans, open market purchases, privately negotiated transactions, block purchases or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934. The stock repurchase program will end upon the earlier of the date on which the plan is terminated by the Board or when all authorized repurchases are completed. The timing and amount of stock repurchases, if any, will be determined based upon our evaluation of market conditions and other factors. The stock repurchase program may be suspended, modified or discontinued at any time, and the Company has no obligation to repurchase any amount of its common stock under the program. The Company did not repurchase any shares of its common stock under this program in the first quarter of 2016. Through March 31, 2016, the Company had repurchased a total of 29,559 shares of its common stock under this program at a cost of approximately $587,000.  At March 31, 2016, approximately $9.4 million was available for future repurchases of the Company’s common stock under this authorization.

 

Commitments and Contractual Obligations

 

There have been no material changes outside the ordinary course of business to our contractual obligations and commitments, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2015.

 

Off-Balance-Sheet Arrangements

 

The Company had no off-balance-sheet arrangements during the three- month period ended March 31, 2016, other than operating leases.

 

ITEM 3:QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

There have been no material changes in our market risks as previously disclosed in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2015.

 

ITEM 4:CONTROLS AND PROCEDURES

 

As of the end of the period covered by this report (the “Evaluation Date”), the Company’s management, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in SEC Rule 13a-15(e) or 15d-15(e)).  Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

There has been no change in the Company’s internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II:OTHER INFORMATION

 

ITEM 1A:RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part 1 - Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

 

ITEM 2:UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Issuer Purchases of Equity Securities

 

On June 16, 2015, the Company issued a press release announcing that its Board of Directors authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock. The Company did not repurchase any shares of its common stock under this program in the first quarter of 2016. Through March 31, 2016, the Company had repurchased a total of 29,559 shares of its common stock under this program at a cost of approximately $587,000.  At March 31, 2016, approximately $9.4 million was available for future repurchases of the Company's common stock under this authorization.

 

ITEM 6:EXHIBITS

 

 

*     Filed herewith.

**   Furnished herewith.

#     Indicates management contract or compensatory plan or arrangement.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

UFP TECHNOLOGIES, INC.

 

 

 

EXHIBIT INDEX

 

*     Filed herewith.

**   Furnished herewith.

#     Indicates management contract or compensatory plan or arrangement.